About EXINI Diagnostics
EXINI Diagnostics AB is a medical imaging AI company that develops advanced automated analysis platforms for nuclear medicine and radiology. Founded in 1999 as a spinout from Lund University research, the company has over 25 years of experience commercializing AI-driven methods for automated medical image analysis. EXINI's product portfolio includes aBSI for bone imaging, aPROMISE for prostate cancer PSMA analysis, CURE8 for brain imaging, and PYLCLARI AI for amyloid imaging. These certified solutions provide quantifiable and reproducible assessments that enable precision oncology and improved diagnostic workflows. The company's technology is trusted by over 800 clinical sites worldwide and focuses on key clinical areas including PSMA imaging for prostate cancer, brain imaging, and bone scan analysis. EXINI serves healthcare providers, pharmaceutical companies, and research institutions with both clinical software and pharma services. The company is headquartered in Lund, Sweden at the Ideon Science Park and operates as a wholly owned subsidiary of Lantheus Holdings, Inc., a publicly traded medical imaging company.
Mission & Story
Mission
To develop and commercialize AI-driven methods for automated medical image analysis
Founding Story
EXINI Diagnostics AB originated from a research group at Lund University with a mission to develop and commercialize AI-driven methods for automated medical image analysis.
Clinical Focus
Medical conditions and clinical areas addressed by EXINI Diagnostics.
Who It Serves
Milestones & Awards
Recent Milestones
Joined EU's Thera4Care Project (October 2024); Released new version of aPROMISE with semi-automatic hotspot drawing and viewport layout features (August 2024); Integrated aPROMISE solution on Siemens Healthineers syngo.via platform demonstrated at SNMMI annual meeting (June 2024)
Awards & Recognition
25+ years of innovation in medical imaging AI, trusted by 800+ sites worldwide
Key Partnerships
Social & Media
Latest Updates
EXINI Executes Agreement with Bayer AG for the Distribution of its PSMA Artificial Intelligence Technology aPROMISE and quantitative assessment technology of bone scans aBSI
EXINI executes agreement with INmune Bio for Phase I/II trial
Lantheus Announces Top Rated Oral Presentation Featuring PYLARIFY AI® at the 2023 EuropeanAssociation of Nuclear Medicine (EANM) Annual Meeting
EXINI Diagnostics AB, a Lantheus company (EXINI), announced today a ‘License and Development’ agreement with Curium, a world leader in nuclear medicine , to customize EXINI’s artificial intelligence (AI) platform for use in Europe.
New version released of PYLARIFY AI® (aPROMISE)
Company Details
- Founded
- 1999
- Headquarters
- Lund, Skåne, Sweden
- Employees
- 11-50
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.